J&J vaccine completely prevented HIV in half of monkeys in trial

By Julie Steenhuysen CHICAGO (Reuters) – An experimental Johnson & Johnson vaccine completely prevented HIV infection in half of monkeys that got the shot and then were exposed to high doses of an aggressive virus, results that spurred the company to test the vaccine in people, academic and company researchers said on Thursday. It is the first time since Merck’s failed 2007 trial that a major pharmaceutical company has sponsored clinical development of an HIV vaccine, said Dr. Dan Barouch, a vaccine researcher at Beth Israel Deaconess Medical Center and the Ragon Institute of Massachusetts General Hosptial, MIT and Harvard. Some 35 million people are infected with HIV, the virus that causes AIDS.
Sexual Health News Headlines – Yahoo! News